Bipolar Disorder Archive
Researchers evaluated the safety and efficacy of lurasidone in children and adolescents with bipolar depression.
Dopamine dysfunction underlies the pathoetiology of psychosis in both bipolar disorder and schizophrenia.
Asenapine decreases the time to recurrence of manic and depressive episodes among patients with bipolar I disorder.
Bright light therapy might be effective for the treatment of bipolar depression.
People with both bipolar disorder and ADHD have similar neurocognitive profiles compared with people with only bipolar disorder.
Olanzapine was shown to be effective among patients with acute mania associated with bipolar I disorder.
Lithium is the only medication to demonstrate an antisuicidal effect over and above its action on mood episodes in bipolar disorder.
An M1-like proinflammatory state is associated with a poor response to antidepressant treatment in bipolar depression with evidence suggesting increased production of cytokines in patients with mood disorders.
Ketamine improves social function and academic performance in juvenile patients with bipolar disorder with a fear of harm phenotype.
For patients with bipolar disorder and major depressive disorder, reduction in dose of antipsychotic medication could lead to an increased rate of hospitalization.
Mixed state does not increase the risk for suicidal behavior beyond the risk associated with the depressive component.
Children and adolescent offspring of patients with schizophrenia demonstrate more attenuated psychotic symptoms.
Psychosis in patients with bipolar disorder was not associated with worse clinical or functional outcomes.
Lithium response may be predicted with better accuracy by a new model.
Mixed and psychotic features and comorbid anxiety disorder were associated with poor treatment response in bipolar disorder.
The risk for mood disorders increases with the more sugar consumed from beverages and food.
Bipolar disorder in youth does not exhibit a cognitive worsening over time.
New bipolar I disorder treatment Abilify Maintena is only required once a month.
Childhood trauma modulates the effects of bipolar disorder on the amygdala and hippocampus by causing an increase in the volumes of gray matter.
Pregnant women with bipolar disorder receiving psychotropic medication did not experience less functional impairment and symptom burden.
Bipolar disorder probability in the offspring of a parent with BP was assessed by a risk calculator.
Bipolar disorder was connected to both sexual distress and overall quality of life.
In bipolar disorder, neurocognitive impairment needs to be considered a therapeutic clinical target to improve psychosocial functioning.
Manic relapse in bipolar disorder is connected to thyroid disease.
Bipolar disorder mood relapse episodes were delayed with risperidone long-acting injection.
Bipolar disorder treatment with lamotrigine during pregnancy may also prevent postpartum depressive episodes.
Depressed patients with diagnoses that ultimately converted to bipolar disorder had been diagnosed with depression earlier.
Emotional stability assessed in late adolescence is inversely associated with serious mental illness.
Neither bipolar disorder nor lithium treatment was associated with increased cancer incidence.
The burden of illness associated with bipolar disorder warrants early preemption.
Irritability may have wide-ranging impacts on symptomatic, functional, and social elements of quality of life.
Careful monitoring of thyroid function is necessary for patients undergoing lithium therapy.
Patients with bipolar disorder saw their quality of life affected by depression, irritability, and other psychiatric conditions.
Bipolar disorder mental health mobile apps containing "wishlists" might not adequately meet consumer needs.
Schizophrenia, mood disorders, and diabetes were among the top 20 conditions with the highest all-cause 30-day readmission rates.
Two OTC supplements may improve brain function and mood control in patients diagnosed with bipolar disorder.
Lithium treatment was not associated with the overall cancer risk in Swedish patients with bipolar disorder in the age group 50-84 years.
Patients discharged with a mood stabilizer and an atypical antipsychotic had the lowest rehospitalization rate.
Immune dysfunction may mediate the link between bipolar disorder and medical comorbidities.
In a new study, teens and young adults with bipolar disorder who had attempted suicide had slightly less volume and activity in areas of the brain that regulate emotion and impulses.
Delays in treatment for psychosis can be associated with poorer outcomes.
While lithium has been the mainstay of treatment for decades, several other classes of medication have recently been used with varying degrees of success.
Atypical antipsychotic adjunctive therapy to mood stabilizers may be more effective than mood stabilizer monotherapy.
For the acute treatment of manic or mixed episodes in bipolar I disorder, the recommended starting and treatment dose is now 5-10mg twice daily.
This study included Medicaid patients taking medications to treat bipolar disorder, schizophrenia, or major depression with psychosis.
Lithium prescription rates for patients with bipolar disorder have declined during the last decade.
Group psychoeducation is a low-cost psychological intervention with specific clinical benefits in early bipolar disorder, if the focus of care is preventing future mania relapse and improving self-management, interpersonal function, and support.
The Mood Zoom questionnaire asks users to rate anxiety, elation, sadness, anger, irritability, and energy on a 7-point Likert scale
Programs conducted in early stages of bipolar disorder to improve cognition and functioning may boost cognitive reserve and thus, help prevent cognitive decline.
One line of future research in this area will be examining whether dorsal attention network connectivity predicts behavioral performance and emotional reactivity.
Approximately 2.5% of people worldwide are estimated to have bipolar spectrum disorders, which are a significant cause of neuropsychiatric disability.
Dr. Scott Zeller suggests it is time to move away from emergency intramuscular haloperidol.
Patients with comorbid bipolar disorder and ADHD may benefit from methylphenidate treatment, if it can be done without incurring the risk of mania.
Intra-subject variability in reaction time (ISVRT) is viewed as a promising behavioral endophenotype for bipolar disorder.
Until now, the majority of postmortem research that has examined functionally related gene sets has been limited to a single disorder or region of the brain.
By using the Washington Early Recognition Center Affectivity and Psychosis (WERCAP) questionnaire, investigators accurately predicted bipolar disorder or schizophrenia in more than 85% of patients.
Findings suggest that in families with 2 generations of direct progenitors with bipolar disorder, an increase in bipolar disorder severity in future generations is likely.
Treatment initiated in the early stages of bipolar disorder was found more effective than treatment in later stages.
Interaction of Proline and COMT Genotype Influences Negative Symptoms in Schizophrenia & Bipolar Disorder
The authors explored whether valproate (VPA) treatment effects vary by catechol-O-methyltransferase (COMT) genotype.
Brain-derived Neurotrophic Factor and its Precursor proBDNF as Diagnostic Biomarkers for Mood Disorders
mBDNF/proBDNF ratio could potentially serve as a novel biomarker for mood disorders.
Insights from the Global Burden of Disease Study 2013
The immune system dysregulation may lead to or exacerbate neuropsychiatric conditions such as bipolar disorder.
Until now, assessment of aerobic exercise capacity included expensive and time-consuming laboratory tests that do not necessarily accurately reflect patients' day-to-day physical functioning.
Irritability in Recovered Bipolar Disorder Patients Linked to Greater Morbidity, Depression Recurrence
Delayed depressive recovery occurred more in depressed patients with current irritability.
Direct comparison of white matter tracts between individuals with schizophrenia or bipolar disorder has not been performed to date.
Psychosocial and Demographic Predictors of Depression Among Individuals With Bipolar Disorder and Schizophrenia
Bipolar disorder and schizophrenia are characterized by significant genetic overlap, as well as significant clinical presentation overlap.
The researchers quantified the transcript levels of GAD67, parvalbumin, somastatin, and Lhx6 in the prefrontal cortex.
Drug comparisons for mood disorders such as bipolar disorder, major depressive disorder, treatment resistant depression, premenstrual dysphoric disorder, and others.
Researchers found that many patients have disruptive symptoms for years before they receive proper treatment.
Investigators examined antibiotic use in patients with bipolar disorder, schizophrenia, and major depressive disorder.
At 12 months, researchers found a significant association between smoking reduction and suicidality.
Genetic risk for psychosis influences reward processing in healthy adolescents.
New findings underline the potential importance of signaling pathways in the striatum for understanding bipolar disorder pathophysiology.
Exposure to Stressful Triggers Increases Risk for Violent Criminality Irrespective of Psychiatric Condition
The largest 7-day absolute risk of criminal violence was observed after exposure to violence in patients diagnosed with schizophrenia, bipolar disorder, as well as in unaffected individuals.
Bipolar disorder (BD) is typically characterized by recurrent episodes of mania and depression, but the connection between BD and anxiety needs to be considered.
Neuroimaging studies have shown several neurophysiological substrates for depression: An overview by Theodore Henderson, MD, PhD.
Events that happen in childhood and adolescence can predispose individuals to suicidal behavior.
University of Washington Tobacco Scholar Joseph Cerimele, MD, MPH, discusses the relationship between smoking and psychiatric illness.
Physical rehabilitation has the potential to improve the performance of daily activities in individuals with bipolar disorder.
Great potential exists for using objective smartphone data to discriminate between depressive and manic states in patients with bipolar disorder.
Research identifies high comorbidity rates between these 2 distinct diseases with underlying inflammation dysfunction.
Research in recent decades has found structural brain abnormalities in patients with bipolar disorder, but such observations had not been translated into objective and clinically useful biomarkers.
Theory of Mind refers to the ability to assign mental states to oneself and others based on social cues such as tone of voice and facial expressions.
Abnormal variations in the gene PDE10A19 might impact signaling of a messaging pathway responsible for learning, memory.
Feasible opportunities for healthy diet and activity linked to intentions, behaviors, and BMI.
Individuals with bipolar disorder or psychosis were 6 times more likely to die by suicide after prior self-harm.
Although not usually considered as part of primary treatment, nutrition addresses the crucial link between food and brain functioning.
Results from a new survey suggest that significant gaps exist in the treatment for adults in the US with major depressive disorder.
New research suggests that a group of drugs being developed for mood disorders could also relieve chronic pain.
For adults, similar efficacy for cognitive behavioral therapy and antidepressants.
Carbamazepine co-treatment linked to subtherapeutic anticoagulative effect of warfarin.
Therapeutic drug monitoring is vastly underused in psychiatry but could better inform clinical decision-making.
Increased risk of any major congenital malformations, major cardiac malformations.
China's U.N. delegation has argued that ketamine is a health risk when it is used in a recreational fashion.
Findings presented for children of parents with major mood and psychotic disorders.
The mixed features specifier identifies a subpopulation that is often misdiagnosed.
Significant association seen in SSRIs and venlafaxine in unipolar depression.
A team of researchers have linked a genetic variant of the SNX7 gene with both elevated levels of kynurenic acid and the disease symptoms of bipolar disorder.
An abandoned drug for stroke treatment may provide a safer treatment than lithium in treating bipolar disorder.
There was a significant difference in six proteins in those with bipolar I depression compared to the control group.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Effectiveness of Exercise in Decreasing Depressive Symptoms
- Obsessive Compulsive Disorder Associated With Decreased Educational Attainment
- Dementia Risk Not Associated With Proton Pump Inhibitor Use
- Antidepressant Effectiveness for Depression in Schizophrenia
- Signs Workplace Stress Affects Mental Health
- Nutritional Psychiatry: Emerging Evidence and Expert Interview
- FDA Approval: Once-Monthly Buprenorphine Injection for Opioid Use Disorder
- Posttreatment Brain Effects of Psilocybin in Patients With Treatment-Resistant Depression
- Bipolar Disorder, Borderline Personality Disorder May Represent the Same Disorder
- Borderline Personality Disorder: Not Just an Adult Condition
- Psychosis Treatment Failure More Common in Patients With ASD
- Psychiatric Risk for Female Offspring of World War II Finnish Evacuees
- Making a Decision: Using Conscious vs Unconscious Thinking to Solve the Problem
- Adult ADHD May Negatively Affect Fibromyalgia-Related Morbidity
- Depression Screening Tools Accurate in Post-Acute Coronary Syndrome